1. Home
  2. RPRX vs TKO Comparison

RPRX vs TKO Comparison

Compare RPRX & TKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • TKO
  • Stock Information
  • Founded
  • RPRX 1996
  • TKO 1980
  • Country
  • RPRX United States
  • TKO United States
  • Employees
  • RPRX N/A
  • TKO N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • TKO
  • Sector
  • RPRX Health Care
  • TKO
  • Exchange
  • RPRX Nasdaq
  • TKO Nasdaq
  • Market Cap
  • RPRX 14.0B
  • TKO 13.1B
  • IPO Year
  • RPRX 2020
  • TKO N/A
  • Fundamental
  • Price
  • RPRX $33.88
  • TKO $158.27
  • Analyst Decision
  • RPRX Strong Buy
  • TKO Strong Buy
  • Analyst Count
  • RPRX 5
  • TKO 14
  • Target Price
  • RPRX $41.60
  • TKO $149.69
  • AVG Volume (30 Days)
  • RPRX 4.6M
  • TKO 1.3M
  • Earning Date
  • RPRX 02-11-2025
  • TKO 02-26-2025
  • Dividend Yield
  • RPRX 2.60%
  • TKO N/A
  • EPS Growth
  • RPRX N/A
  • TKO N/A
  • EPS
  • RPRX 1.91
  • TKO N/A
  • Revenue
  • RPRX $2,263,576,000.00
  • TKO $2,776,140,000.00
  • Revenue This Year
  • RPRX $29.18
  • TKO $66.87
  • Revenue Next Year
  • RPRX $9.99
  • TKO $15.42
  • P/E Ratio
  • RPRX $17.69
  • TKO N/A
  • Revenue Growth
  • RPRX N/A
  • TKO 108.30
  • 52 Week Low
  • RPRX $24.05
  • TKO $78.69
  • 52 Week High
  • RPRX $34.16
  • TKO $179.09
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 80.55
  • TKO 47.10
  • Support Level
  • RPRX $32.28
  • TKO $157.71
  • Resistance Level
  • RPRX $34.20
  • TKO $179.09
  • Average True Range (ATR)
  • RPRX 0.71
  • TKO 5.77
  • MACD
  • RPRX 0.02
  • TKO -2.04
  • Stochastic Oscillator
  • RPRX 89.40
  • TKO 4.93

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About TKO TKO Group Holdings Inc.

TKO Group Holdings Inc is a premium sports and entertainment company that comprises UFC, the world's mixed martial arts organization, and WWE, an integrated media organization and the recognized leader in sports entertainment.

Share on Social Networks: